Order Tag

A population analysis of pooled data from the two large controlled studies in patients with metastatic colorectal cancer n 505 who were administered xeloda at 1250 mg m 2 twice a day indicated that gender 202 females and 303 males and race 455 white caucasian patients, 22 black patients, and 28 patients of other race have no influence on the pharmacokinetics of 5 -dfur, 5-fu and fbal.